The Latest Breaking News from Sleep Apnea

While we've been expecting the Apple Watch Series 10 and Ultra 3 to debut at Apple's Sept. 9 event, a new report sheds light on the next health feature arriving to the wearable.

A doctor of sleep medicine shares their top four tips for how to stop snoring immediately and regain some peace and quiet in the bedroom at night.

Weight-loss drugs’ impact could reach far beyond their target user, potentially creating headwinds for shares of snack makers and packaged-food firms, as well as medical device makers that specialize in knee replacements, insulin pumps and sleep apnea machines.

A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep

ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.

ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.

Eli Lilly's Zepbound drug shows promise in treating obstructive sleep apnea by reducing symptoms and promoting weight loss.

Eli Lilly stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events.

From hormonal imbalances to psychological struggles and domestic duties, for World Sleep Day we explore the diverse factors that help create the gender sleep gap.